Somewhat Positive Media Coverage Somewhat Unlikely to Impact Allscripts Healthcare Solutions (NASDAQ:MDRX) Stock Price
Media coverage about Allscripts Healthcare Solutions (NASDAQ:MDRX) has been trending somewhat positive recently, according to Accern Sentiment Analysis. The research group identifies negative and positive press coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Allscripts Healthcare Solutions earned a daily sentiment score of 0.18 on Accern’s scale. Accern also assigned media headlines about the software maker an impact score of 45.565897673782 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.
Here are some of the media headlines that may have impacted Accern’s rankings:
- Alliancebernstein LP Has $1.71 Million Stake in Allscripts Healthcare Solutions, Inc. (MDRX) (overnewsmagazine.com)
- Allscripts Healthcare Solutions (NASDAQ:MDRX) Sees Significantly Higher Trading Volume (techkenyot.com)
- How Many Allscripts Healthcare Solutions Inc (NASDAQ:MDRX)’s Analysts Are Bullish? (topactu.net)
- Allscripts Healthcare Solutions (NASDAQ:MDRX) & Press Ganey Holdings (PGND) Financial Review (americanbankingnews.com)
- Allscripts Healthcare Solutions (NASDAQ:MDRX) Closed Much Higher Than Its 50 Day Moving Average – First News 24 (firstnewspaper24.com)
MDRX has been the topic of several research reports. Zacks Investment Research raised Allscripts Healthcare Solutions from a “sell” rating to a “hold” rating in a report on Wednesday, April 19th. Leerink Swann lowered Allscripts Healthcare Solutions from an “outperform” rating to a “market perform” rating and lowered their target price for the company from $15.00 to $13.00 in a report on Monday, June 19th. Cantor Fitzgerald reissued a “neutral” rating and issued a $13.00 target price on shares of Allscripts Healthcare Solutions in a report on Monday, May 15th. Maxim Group reaffirmed a “buy” rating and set a $16.00 price objective on shares of Allscripts Healthcare Solutions in a research note on Monday, May 15th. Finally, BidaskClub raised Allscripts Healthcare Solutions from a “sell” rating to a “hold” rating in a research note on Saturday, June 24th. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and nine have issued a buy rating to the company’s stock. Allscripts Healthcare Solutions has a consensus rating of “Hold” and an average price target of $14.66.
Shares of Allscripts Healthcare Solutions (MDRX) traded up 2.59% during midday trading on Friday, hitting $12.67. The company had a trading volume of 2,102,061 shares. The company’s 50 day moving average is $12.50 and its 200 day moving average is $12.16. The firm’s market cap is $2.29 billion. Allscripts Healthcare Solutions has a one year low of $9.80 and a one year high of $13.70.
Allscripts Healthcare Solutions (NASDAQ:MDRX) last announced its quarterly earnings results on Thursday, August 3rd. The software maker reported $0.11 earnings per share for the quarter, missing analysts’ consensus estimates of $0.15 by $0.04. Allscripts Healthcare Solutions had a negative return on equity of 54.26% and a negative net margin of 33.56%. The company had revenue of $426.10 million during the quarter, compared to analyst estimates of $424.94 million. During the same period in the prior year, the firm earned $0.14 EPS. Allscripts Healthcare Solutions’s quarterly revenue was up 10.2% on a year-over-year basis. Equities analysts forecast that Allscripts Healthcare Solutions will post $0.62 earnings per share for the current fiscal year.
In other Allscripts Healthcare Solutions news, President Richard J. Poulton sold 25,000 shares of the business’s stock in a transaction dated Tuesday, May 16th. The stock was sold at an average price of $12.06, for a total value of $301,500.00. Following the completion of the sale, the president now owns 412,488 shares of the company’s stock, valued at $4,974,605.28. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 0.75% of the stock is owned by insiders.
Allscripts Healthcare Solutions Company Profile
Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.
Receive News & Ratings for Allscripts Healthcare Solutions Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.